Watch IMNN. Know when insiders buy.
One email the day a filing lands. Free.
Work order
75
PASS · insiders 50, shorts 100
Insiders, 90 days
−$4K
net selling · 0 buys, 1 sell
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $8.9MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$14.7MNET CASH $784K52W 1.51 – 5.82SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$2.8M | −$2.8M | — | -0.54 | −$3M | — | — | Aug 11 |
| Q1 2026 · Mar 31 | — | — | — | −$4.3M | −$4.2M | — | -0.84 | −$4M | — | — | May 12 |
| Q4 2025 · Dec 31derived | — | — | — | −$4.3M | −$4.2M | — | -1.30 | −$3.7M | $4K | −$3.7M | Mar 31 |
| Q3 2025 · Sep 30 | — | — | — | −$3.5M | −$3.4M | — | -1.16 | −$4.4M | $0 | −$4.4M | Nov 13 |
| Q2 2025 · Jun 30 | — | — | — | −$2.8M | −$2.7M | — | -2.15 | −$3M | $17K | −$3M | Aug 11 |
| Q1 2025 · Mar 31 | — | — | — | −$4.1M | −$4.1M | — | -3.15 | −$2.8M | $260K | −$3.1M | May 12 |
| Q4 2024 · Dec 31derived | — | — | — | −$4.1M | −$4.1M | — | -2.81 | −$4.4M | $15K | −$4.4M | Mar 31 |
| Q3 2024 · Sep 30 | — | — | — | −$5M | −$4.8M | — | -3.76 | −$4.1M | $3K | −$4.1M | Nov 13 |
| Q2 2024 · Jun 30 | — | — | — | −$5M | −$4.8M | — | -7.64 | −$4.5M | $0 | −$4.5M | Aug 5 |
| Q1 2024 · Mar 31 | — | — | — | −$5M | −$4.9M | — | -0.52 | −$5.9M | $12K | −$5.9M | May 12 |
| Q4 2023 · Dec 31derived | — | — | — | −$6M | −$4.9M | — | -0.52 | −$3.8M | $0 | −$3.8M | Feb 27 |
| Q3 2023 · Sep 30 | — | — | — | −$3.9M | −$3.5M | — | -0.37 | −$4.5M | $240K | −$4.7M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Jul 28 | — | — | — | — | — | — | — | — | — | — | — |
| FY2025 · to Dec 31 | — | — | −$14.7M | −$14.5M | — | -6.83 | −$13.9M | $281K | −$14.2M | — | — |
| FY2024 · to Dec 31 | — | — | −$19.1M | −$18.6M | — | -16.94 | −$18.9M | $30K | −$18.9M | — | — |
| FY2023 · to Dec 31 | — | — | −$21M | −$19.5M | — | -2.16 | −$19M | $452K | −$19.5M | — | — |
| FY2022 · to Dec 31 | $500K | — | −$24.9M | −$35.9M | -7179.6% | -5.03 | −$23.1M | $268K | −$23.4M | — | — |
| FY2021 · to Dec 31 | $500K | — | −$21M | −$20.8M | -4153.9% | -3.83 | −$16.2M | $312K | −$16.5M | — | — |
Every number comes from Imunon, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.